Condition: Breast Cancer · Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
This study aims to evaluate the efficacy and safety of TQB2102 for injection in HER2 negative recurrent/metastatic breast cancer.
This description comes directly from the study's public registry record.
Kunwei Shen, Doctor · 13916612760 · kwshen@medmail.com.cn
Always discuss trial participation with your own doctor first.
| Bozhou People's Hospital | Bozhou, Anhui, China | Not Yet Recruiting |
| Chuzhou First People's Hospital | Chuzhou, Anhui, China | Not Yet Recruiting |
| Anhui Provincial Public Health Clinical Center | Hefei, Anhui, China | Not Yet Recruiting |
| Ma'anshan People's Hospital | Ma’anshan, Anhui, China | Not Yet Recruiting |
| Wuhu Hospital Affiliated to East China Normal University | Wuhu, Anhui, China | Not Yet Recruiting |
| Harbin Medical University Cancer Hospital | Harbin, Heilongjiang, China | Not Yet Recruiting |
| The Third People's Hospital of Zhengzhou | Zhengzhou, Henan, China | Not Yet Recruiting |
| The First People's Hospital of Zhengzhou | Zhengzhou, Henan, China | Recruiting |
| Zhongnan Hospital of Wuhan University | Wuhan, Hubei, China | Not Yet Recruiting |
| The First People's Hospital of Changde City | Changde, Hunan, China | Not Yet Recruiting |
| Ruijin Hospital ,Shanghai Jiao Tong University School of Medicine | Shanghai, Shanghai Municipality, China | Not Yet Recruiting |
| The First Affiliated Hospital of Xi'an Jiaotong University | Xi’an, Shanxi, China | Not Yet Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06452706